Avinger is a commercial-stage medical device company that designs, manufactures and sells real-time image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Co.'s proprieary image-guided Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion, and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. We show 25 historical shares outstanding datapoints in our AVGR shares outstanding history coverage, used to compute AVGR market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing AVGR market cap history over the course of time is important for investors
interested in comparing AVGR's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of AVGR versus a peer is one thing; comparing
AVGR market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like AVGR can fluctuate over the course of history.
With this page we aim to empower investors researching AVGR by allowing them to research the AVGR market cap history. |
Free AVGR Email Alerts:
Video: The Importance of Market Cap
